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  Covalently closed circular DNA (cccDNA) forms a template for the replication of 
hepatitis B virus (HBV) and duck HBV (DHBV). Recent studies suggest that 
activation-induced cytidine deaminase (AID) functions in innate immunity, although its 
molecular mechanism of action remains unclear, particularly regarding HBV restriction. 
Here we demonstrated that overexpression of chicken AID caused hypermutation and 
reduction of DHBV cccDNA levels. Inhibition of uracil-DNA glycosylase (UNG) by 
UNG inhibitor protein (UGI) abolished AID-induced cccDNA reduction, suggesting 
that the AID/UNG pathway triggers the degradation of cccDNA via cytosine 




• AID reduced DHBV NC-DNA and cccDNA in chicken hepatoma cells. 
• AID induced G-to-A and C-to-T hypermutations in cccDNA. 
• UNG inhibition abolished AID-induced reduction of cccDNA but not NC-DNA. 








AID, activation-induced cytidine deaminase; APOBEC, apolipoprotein B 
mRNA-editing enzyme catalytic subunit; UNG, uracil-DNA glycosylase; DHBV, duck 
hepatitis B virus; cccDNA, covalently closed circular DNA; 3D-PCR, differential 




  The covalently closed circular DNA (cccDNA) of the hepatitis B virus (HBV) plays 
an essential role in chronic hepatitis. cccDNA exists as an episome in the nucleus of 
infected hepatocytes and transcribes all viral RNAs, including pregenomic (pg) RNA. 
pgRNA is assembled into the nucleocapsid (NC) in the cytoplasm and is then converted 
into a relaxed circular DNA (rcDNA) by viral polymerase activity. Mature NCs are 
secreted after combining with envelope proteins or translocated to the nucleus. In the 
nucleus, the rcDNA is again converted into cccDNA for the next replication cycle. Only 
one or a few copies of cccDNA per infected cell are stably maintained by an unknown 
mechanism [1]. 
  Despite the crucial role of cccDNA in viral persistence, little is known about the host 
factors that target this viral nuclear intermediate owing to the absence of an efficient 
experimental system that can produce HBV cccDNA at a level sufficient for analysis. In 
view of the limitation of HBV in vitro systems, the duck HBV (DHBV) model has been 
commonly used to study HBV replication [2]. Recently, we reported that an anti-viral 
factor APOBEC3G (A3G) induces hypermutation on DHBV cccDNA [3]. A3G belongs 
to the APOBEC (apolipoprotein B mRNA-editing catalytic polypeptide) family of 
proteins. In humans, this family comprises at least 11 members including AID and 
APOBEC-1, -2, -3A, -3B, -3C, -3DE, -3F, -3G, -3H and -4. These AID/APOBEC 
proteins have enzymatic activity that can deaminate a cytosine base in DNA and/or 
RNA, thereby generating a uracil base. A3G is known to restrict the replication of 
retroviruses, including human immunodeficiency virus type 1 (HIV-1), HBV and 
retrotransposable elements [4-6]. AID was initially identified as an essential factor for 
class-switch recombination (CSR) and somatic hypermutation (SHM) of 
immunoglobulin genes in B cells [7,8]. It was also found that AID is expressed in 
response to cytokine stimulation in human hepatocytes [9] and HBV patients [10], 
induces HBV hypermutation in NC-DNA [10] and pgRNA [11] and restricts viral 
replication [12]. It remains to be established whether AID targets hepadnavirus 
cccDNA. 
  UNG is a host nuclear factor that removes uracil bases from uracilated DNA and 
initiates base excision repair (BER), resulting in DNA repair or cleavage [13]. The 
involvement of UNG activity in A3G-induced viral restriction has been vigorously 
studied in the HIV field, but remains a subject of debate [14-17]. We previously 
demonstrated that UNG repairs DHBV cccDNA hypermutation induced by A3G [3]. 
The involvement of UNG in the anti-HBV activity of AID is of interest because AID is 
well known to initiate CSR and SHM by coupling with downstream UNG-directed BER 
pathways [13,18]. 
  Here we investigated the effects of chicken AID on DHBV replication using an in 
vitro DHBV replication system with a chicken hepatoma cell line LMH, which we 
utilized to analyse cccDNA formation and function [2,19,20]. We found that the 
expression of chicken AID in LMH cells resulted in the reduction of DHBV NC-DNA 
and cccDNA. Furthermore, UNG inhibition abolished AID-induced reduction of 
cccDNA but not NC-DNA, suggesting that viral DNA degradation is induced by the 
AID/UNG pathway in the nucleus. 
 
2. Materials and Methods 
 
2.1. Plasmids 
  The DHBV replicon plasmid pCSD3.5ΔS [21] and UGI expression vector 
pIRES-UGI [3] were described previously. The pCSD3.5ΔS plasmid produces a DHBV 
surface-deficient mutant that accumulates cccDNAs more efficiently than wild-type 
DHBV [20,21]. Other expression vectors are described in the Supporting Methods. 
 
2.2. Cell culture and transfection 
  LMH cells were maintained in Dulbecco’s modified Eagle medium (DMEM; Sigma, 
St. Louis, MO, USA) containing 10% foetal bovine serum, 100 U/mL penicillin and 
100 µg/mL streptomycin. Plasmid transfection was performed using Fugene 6 (Roche, 
Basel, Switzerland), according to the manufacturer’s instructions. The total DNA 
amount (6 µg for a 60-mm dish) for each transfection was kept constant by adding 
mock vector as needed. The ER-fusion protein that was expressed as an inactive form 
was activated by tamoxifen (OHT, Wako Pure Chemical Industries, Osaka, Japan) 
treatment [22]. In the subcellular localization experiments of GFP fusion proteins, cells 
were treated with 10 ng/mL leptomycin B (LMB, Sigma) for 4 h. 
 
2.3. Purification of viral DNAs 
  Cells were lysed in 0.5% NP40 lysis buffer, and nuclei were collected by 
centrifugation to separate the cytoplasmic and nuclear fractions. Cytoplasmic 
supernatants were treated with DNase I and RNase A and digested with proteinase K 
and sodium dodecyl sulphate (SDS) to extract viral NC-DNA. A modified Hirt 
extraction procedure was used to extract cccDNA from the nuclear fraction [3]. The 
nuclear pellet was lysed in 50 mM Tris–HCl (pH 7.5), 10 mM EDTA and 2% SDS. 
After a 20-min incubation at room temperature, 0.5 M KCl was added to the lysate and 
incubated at 4°C overnight. All purified DNA solutions were treated with DpnI 
restriction enzyme to digest any transfected plasmid DNA. 
 
2.4. Mutation analysis 
  Hypermutation was detected using differential DNA denaturation PCR (3D-PCR) 
with DHBV cccDNA-selective primers. The specific amplification of cccDNA with 
cccDNA-selective primers was verified previously [3]. 3D-PCR was performed as 
follows: initial denaturation for 5 min at 94–83°C, followed by 35 cycles of 30 s at 
94–83°C, 30 s at 55°C and 2 min at 72°C, with a final elongation for 7 min at 72°C. To 
determine the hypermutation frequency, PCR fragments were cloned into T vectors 
(Promega, Madison, WI, USA). Successfully recombined clones were randomly 
selected and sequenced using ABI PRISM 3130 (Applied Biosystems, Foster City, CA, 
USA). 
 
2.5. Southern blotting 
  Purified DHBV DNAs were analysed by Southern blotting using double-stranded 
DHBV DNA probes spanning the entire viral genome. Probe labelling and signal 
development were performed using the AlkPhos direct labelling system (GE Healthcare, 
Piscataway, NJ, USA), and signals were detected using the LAS1000 imager system 
(GE Healthcare). 
 
2.6. Rolling circle amplification (RCA) 
  Specific amplification of DHBV cccDNA by RCA method was described previously 
[3,23]. The RCA concatemerized product was converted to the monomeric full-length 
DHBV genome by digestion with EcoRI, which cuts the DHBV cccDNA once. After 
electrophoresis, the DNA fragments were analysed by Southern blotting. 
 
2.7. Western blotting 
  Transgene expression was analysed by Western blotting as described previously [3]. 
The following antibodies were used in this study: rabbit anti-GAPDH (G9545, Sigma), 
mouse anti-FLAG (M2, Sigma), rabbit anti-ER (HC-20, Santa Cruz Biotechnology, CA, 
USA) and anti-rabbit Igs-horseradish peroxidase (HRP) (ALI3404, eBioscience, San 




3.1. Chicken AID induced cccDNA reduction via a UNG-dependent pathway 
  A DHBV replication system in a chicken hepatoma cell line LMH was utilized to 
analyse cccDNA. With this in vitro system, we could detect cccDNA by Southern 
blotting of nuclear Hirt extracts (Fig. 1A). The three DNA forms (rc, dl and cccDNA) in 
the nuclear Hirt extract were all converted into dlDNA position as 3.0-kb bands after 
EcoRI digestion (Fig. 1A). To investigate the anti-DHBV activity of AID, a chicken 
AID expression vector and DHBV replicon plasmid pCSD3.5 were transfected into 
LMH cells. Concurrently, the effect of UNG inhibition was also tested by 
co-transfection of a UGI expression vector. UGI is an irreversible inhibitory protein that 
forms a stable complex with UNG. We previously demonstrated a 91% reduction of 
UNG activity under the conditions shown in Fig. 1B [3]. Six days after transfection, 
cytoplasmic nucleocapsid (NC)-DNAs and nuclear Hirt-extracted DNAs were purified. 
Southern blotting showed that AID overexpression reduced DHBV NC-DNA and 
cccDNA (Fig. 1B). UNG inhibition by UGI abolished AID-induced reduction of 
cccDNA but not NC-DNA. We confirmed that the protein level of chicken AID was not 
affected by UGI overexpression (Fig. 1C). 
  To determine cccDNA level at an earlier time point, we used RCA, a highly sensitive 
method widely used to measure the level of closed circular DNA of various viral 
species [24]. Three days after transfection, cccDNA from nuclear Hirt-extracted DNAs 
was amplified by RCA and digested with EcoRI to cleave the concatemer into 
monomers of full-length viral genomes (3.0 kb). Amplified cccDNA was detected by 
Southern blotting. Consistent with data obtained from day 6 (Fig. 1B), AID 
overexpression reproducibly suppressed both NC-DNA and cccDNA levels and UGI 
abolished the reduction of only cccDNA at day 3 (Fig. 2A and B). 
 
3.2. Chicken AID induced cccDNA hypermutation 
  Next, we investigated the hypermutation activity of AID for DHBV cccDNA by 
3D-PCR using cccDNA-specific primers (Fig. 3A). 3D-PCR can detect hypermutated 
DNA by gradually decreasing the denaturation temperature [25]. Our results showed 
that only AID–UGI co-expression resulted in lower temperature amplification (83.9°C 
and 83.0°C, indicated by triangles in Fig. 3B). Sequence analysis of DNA amplified at 
the lower denaturation temperature revealed G-to-A and C-to-T hypermutations (Fig. 
3C and D and Fig. S1). Dinucleotide context analysis of the hypermutated cccDNA 
showed a preference for GpC and ApC dinucleotides as a mutation target (Fig. 3E), 
which is consistent with a previous report of human AID-induced HBV hypermutation 
[10]. 
 
3.3. Chicken AID is a protein that shuttles between the cytoplasm and nucleus 
  Chicken AID has a nuclear localization signal (NLS) in the N-terminus and a nuclear 
export signal (NES) in the C-terminus [26]. To determine the subcellular localization of 
chicken AID in chicken hepatocytes, an AID–GFP vector was transfected into LMH 
cells. Similar to human AID [27], chicken AID–GFP protein localized predominantly in 
the cytoplasm (Fig. 4A). Cells were treated with leptomycin B (LMB) to inhibit 
exportin 1-dependent nuclear export [27,28]. LMB treatment for 4 h changed the 
localization of AID from the cytoplasm to both cytoplasm and nuclear. Consistent with 
this observation, deletion of C-terminal residues containing NES (AIDΔNES in Fig. 4B, 
corresponding to JP8Bdel human mutant) resulted in the nuclear localization of AID 
with minor cytoplasmic retention (Fig. 4A). These observations indicate that chicken 
AID shuttles between the cytoplasm and nucleus in LMH cells and that the subcellular 
localization pattern of AID is conserved in mammals and chicken. 
 
3.4. Nuclear retention of AID enhanced cccDNA-reduction activity 
  Because the majority of AIDΔNES–GFP protein was localized mainly to the nucleus, 
we examined the cccDNA-reduction activity of this mutant. Wild-type AID or 
AIDΔNES was co-transfected with a DHBV plasmid. Southern blotting following RCA 
showed that AIDΔNES had a stronger DHBV cccDNA-reduction activity than 
wild-type AID, whereas reduction of cytoplasmic NC-DNA levels by AIDΔNES was 
slightly weaker than that by wild-type AID (Fig. 5A). Protein levels of AIDΔNES were 
equivalent to that of wild-type AID (Fig. 5B). These data suggest that nuclear-localized 




  In this study, we overexpressed chicken AID and inhibited UNG activity in LMH 
cells to evaluate anti-viral roles of AID and UNG against DHBV. We found that AID 
reduced both DHBV NC-DNA and cccDNA levels, and UNG inhibition abolished the 
reduction of cccDNA but not NC-DNA (Fig. 1 and 2). The UNG inhibition also 
revealed the AID-induced G-to-A and C-to-T hypermutation in cccDNA (Fig. 3). 
Furthermore, a nuclear-localized AID mutant more strongly reduced cccDNA levels 
than wild-type AID (Fig. 5). These results suggest that AID introduces C-to-U 
conversion in both strands of cccDNA and that UNG-mediated BER may degrade 
uracilated cccDNA (Fig. 6). 
  This study suggests that the molecular mechanism of AID-induced NC-DNA 
reduction could be different from that for cccDNA because it was found to be 
UNG-independent. We previously showed a physical association between human AID 
and HBV core proteins [11], suggesting the encapsidation of AID proteins in NC as 
reported in the case of A3G. Unlike HIV, UNG incorporation was not detected in HBV 
NC [3], implying no or little contribution of BER-mediated DNA cleavage in NC-DNA 
restriction. Similar to A3G [29,30], AID may suppress NC-DNA formation through 
deaminase-independent activity such as inhibition of reverse transcription. We also 
obtained the result, suggesting that human P19-AID mutant carrying a mutation in the 
deaminase motif [31] has the ability to reduce HBV NC-DNA as efficiently as 
wild-type AID (unpublished). In contrast, when AID deaminates cccDNA in nucleus, 
UNG-mediated BER can efficiently excise uracils from cccDNA and cleave DNA, 
similar to the case of the immunoglobulin gene undergoing CSR [13,18]. This can be a 
reason why cccDNA reduction was abolished by UNG inhibition.  
  Our previous study revealed that A3G reduces both DHBV cccDNA and NC-DNA 
[3]. In contrast to AID, cccDNA reduction by A3G was not abolished when UNG was 
inhibited. It is likely that AID has a different activity from A3G to suppress cccDNA. 
cccDNA reduction by A3G may simply be reflected by the reduction of NC-DNA, 
whereas de novo cccDNA degradation could be triggered by nuclear-localized AID 
followed by UNG activity (Fig. 6). Enhancement of cccDNA-reduction activity in the 
AIDΔNES mutant (Fig. 5) supports the idea that AID is directly targeted to nuclear 
cccDNA. Furthermore, mutation analysis showed AID-induced hypermutation in both 
strands of cccDNA (Fig. 3), which is different from the A3G-induced hypermutation 
exclusively occurring in the minus strand DNA [3]. cccDNA reduction mediated by the 
AID/UNG pathway can be explained by double-strand breaks initiated by deamination 
of both strands. AID is proposed to recruit UNG to the immunoglobulin gene to cause 
CSR [32]. We speculate that such a property may also underlie the different outcomes 
in cccDNA reduction observed between AID and A3G. 
  Recently, Vartanian et al. clearly demonstrated that APOBEC3 proteins are major 
deaminases that cause HBV NC-DNA hypermutation in vivo using dinucleotide context 
analysis of hypermutated NC-DNA obtained from patients [10]. However, the 
contribution of AID to cccDNA reduction and deaminase-independent NC-DNA 
reduction was still unknown in vivo. Our data suggests cccDNA as a novel target of the 
anti-HBV activity of AID for the first time. Further studies are required to reveal the 
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Fig. 1. Chicken AID induced DHBV cccDNA reduction depending on UNG activity. 
(A) Southern blotting for DHBV DNA. The DHBV replicon plasmid pCSD3.5ΔS was 
transfected into LMH cells. Six days later, cells were harvested and cytoplasmic 
NC-DNA and nuclear Hirt-extracted DNA were purified. Nuclear sample without 
EcoRI treatment showed two bands at the expected positions of relaxed circular (rc) 
DNA and cccDNA, respectively. Treatment with EcoRI (a single cutter for the DHBV 
genome) resulted in conversion of both bands into one band at the position of 
double-stranded linear (dl) DNA. (B) Expression vectors for chicken AID-ER, UGI-ER 
and Mock-ER were used to transfect LMH cells with pCSD3.5ΔS. The ER-fusion 
protein was expressed as an inactive form that could be activated by tamoxifen (OHT) 
treatment [22]. OHT was added 3 days after transfection and cells were harvested at day 
6. The cytoplasmic NC-DNA and nuclear Hirt-extracted DNA were purified from the 
indicated transfectants and subjected to Southern blotting with a DHBV probe. The 
percent density of each band is indicated (top, rcDNA in NC; bottom, cccDNA in 
nucleus). The density of the negative control (Mock-GFP) was defined as 100%. (C) 
Exogenous protein expression of chicken AID- and Mock-ER was detected by Western 
blotting with anti-ER antibody. pIRES-UGI was used to test whether UGI affects AID 
expression levels. Expression of GAPDH is also shown to demonstrate equivalent 
protein loading. 
 
Fig. 2. Rolling circle amplification (RCA) analysis of cccDNA. Three days after 
transfection (OHT stimulation for 2 days), cytoplasmic NC-DNA and nuclear 
Hirt-extracted DNA were purified. (A) Southern blotting for the cytoplasmic NC-DNA. 
(B) Semi-quantification by cccDNA-specific amplification. The Hirt-extracted DNAs 
were serially diluted to 1:4 and 1:16 as shown in (B) and subjected to RCA with phi29 
DNA polymerase. Concatemeric viral DNA were digested with EcoRI and analysed by 
Southern blotting. 
 
Fig. 3. Chicken AID induced DHBV cccDNA hypermutation. (A) A schematic 
representation of cccDNA-selective primers. Left, cccDNA; right, rcDNA with gaps in 
both strands (− and +), which leads to inefficient amplification of rcDNA with the 
cccDNA-selective primers [3]. (B) 3D-PCR analysis of DHBV cccDNA. The 
Hirt-extracted DNA from each transfectant was analysed by 3D-PCR with a 
denaturation temperature (Td) gradient of 94.0°C, 85.3°C, 83.9°C and 83.0°C. PCR 
fragments (83.9°C and 83°C) indicated by triangles were sequenced, and results from 4 
independent clones are shown in C-E. (C) Mutation matrix of cccDNA from AID–UGI 
transfectants. (D) Proportion of G-to-A and C-to-T mutations per clone. (E) 
Dinucleotide context analysis of C-to-T and G-to-A hypermutations. Underlined 
characters indicate mutated residues. The expected and observed frequencies are shown 
in white and black bars, respectively. 
 
Fig. 4. Chicken AID is a protein that shuttles between the cytoplasm and nucleus. 
(A) Chicken AID-GFP or AIDΔNES-GFP was transfected into LMH cells. The nucleus 
was visualized by co-transfection of the DsRed-NLS vector. LMB was treated for 4 h to 
block nuclear export. LMB treatment caused accumulation of AID–GFP in the nucleus. 
(B) Domain structure of chicken AID. Numbers indicate amino acid residue positions. 
NLS, nuclear localization signal; NES, nuclear export signal. 
 
Fig. 5. Deletion of NES domain enhanced the cccDNA-reduction activity of chicken 
AID. (A) Southern blotting for cytoplasmic NC-DNA and RCA-amplified cccDNA. 
Three days after transfection (OHT stimulation for 2 days), DHBV DNAs were 
analysed. (B) Exogenous protein expression of wild-type AID- and AIDΔNES-ER was 
detected by Western blotting with anti-ER antibody. Expression of GAPDH is also 
shown to demonstrate equivalent protein loading. 
 
Fig. 6. A proposed model for AID-induced DHBV cccDNA reduction. Chicken AID 
shuttles between the cytoplasm and nucleus. Cytoplasmic AID reduces NC-DNA levels, 
presumably by an UNG-independent mechanism. Nuclear AID deaminates cccDNA, 
and then uracilated cccDNA can be cleaved by the UNG-mediated BER pathway. 










































Supporting Figure Legend 
 
Fig. S1. Alignment of hypermutated DHBV sequences. PCR fragments from the 
83.9°C denaturation temperature reaction in Fig. 3B were excised from the agarose gel 
and cloned into T vectors. Subsequently, four randomly selected clones were sequenced. 
The reference sequence from the replicon plasmid is shown above. Dots in the 

















































































  A DNA fragment encoding the oestrogen receptor was amplified from pFERp [3] 
using the primers AAAGGATCCAGATTACAAGGA and 
TTTTTGCGGCCGCTCATCAAGCTGTGGCA, digested with BamHI and NotI and 
inserted into the BamHI/NotI site of pEGFP-N1 (Clontech, Mountain View, CA, USA) 
to prepare pCMVfER. A multiple cloning site in pCMVfER was modified by inserting 
synthetic double-stranded DNAs (5′-GAATTCCGGAACTAGTCGACGGATCC-3′ and 
5′-GAATTCTAGCACCATGGCTAAGGATCC-3′) into the EcoRI/BamHI site and the 
constructed vectors were designated pCMVfER2 and pCMVmockER, respectively. 
pCMVmockER was used to express the Mock-ER protein. A chicken AID open reading 
frame (NM_001243222) [26] was amplified with the primers 
5′-AAGAATTCACCATGGACAGCCTCTTGATGA-3′ and 
5′-TTTTGTCGACGTAAGTCCCAGAGTTTTAAAGGCA-3′, trimmed with 
EcoRI/SalI and inserted into the EcoRI/SalI site of pCMVfER2 or pEGFP-N1 to 
prepare chicken AID–ER or AID–GFP expression vectors, respectively. An open 
reading frame of chicken AIDΔNES was amplified with the primers 
5′-AAGAATTCACCATGGACAGCCTCTTGATGA-3′ and 
5′-AAAAGGATCCGGCAGAAGTATCCGTCGGAGTTTCCTGGA-3′, trimmed with 
EcoRI/BamHI and inserted into the EcoRI/BamHI site of pCMVfER or pEGFP-N1 to 
prepare chicken AIDΔNES–ER or AIDΔNES–GFP expression vectors. A DNA 
fragment of UGI was generated by PCR with the primers 
5′-AAAGAATTCATGACAAATTTATCTGAC-3′ and 
5′-AAAGGATCCGCTAACATTTTAATTTTA-3′, trimmed with EcoRI/BamHI and 
inserted into the EcoRI/BamHI site of pCMVfER to prepare UGI–ER expression vector. 
All plasmids derived from PCR products and their cloning junctions were verified by 
DNA sequencing. 
 
 
 
 
